Miriam Koschorke
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Miriam Koschorke has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Collene E. Anderson
Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, Switzerland
4 shared publications - Lara Stächele
Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, Switzerland
4 shared publications - Lorenz Leitner
Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, Switzerland
4 shared publications - Oliver Gross
Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, Switzerland
4 shared publications - Thomas Matthias Kessler
Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, Switzerland
4 shared publications - Ulrich Mehnert
Department of Neuro-Urology, Balgrist University Hospital, University of Zürich, Zürich, Switzerland
4 shared publications
Latest Publications
- Open Access
- 2 August 2023
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 23 (1) , 1-10
Indwelling catheter vs intermittent catheterization: is there a difference in UTI susceptibility?
Background: Patients with neurogenic lower urinary tract dysfunction (NLUTD) often rely on some type of catheterization for bladder emptying. Intermittent catheterization (IC) is considered the gold standard and is preferred over continuous catheterization, since it is considered to cause fewer urinary tract infections (UTIs) than indwelling catheterization. The main objective of our study was to describe UTI prevalence (at visit) and incidence (within the last 12 months) and urine culture characteristics between patients using an indwelling catheter versus (vs) those performing IC. Methods: In this cross-sectional study, we prospectively evaluated from 02/2020 to 01/2021 patients with NLUTD undergoing urine cultures for prophylactic reasons or due to UTI symptoms. At visit, all patients underwent a standardized interview on current UTI symptoms as well as UTI history and antibiotic consumption within the past year. Patients using an indwelling catheter (n = 206) or IC (n = 299) were included in the analysis. The main outcome was between-group differences regarding UTI characteristics. Results: Patients using an indwelling catheter were older (indwelling catheter vs IC: median 66 (Q1-Q3: 55—77) vs 55 (42—67) years of age) and showed a higher Charlson comorbidity index (indwelling catheter vs IC: median 4 (Q1-Q3: 2–6) vs 2 (1–4) (both p < 0·001). A total of 40 patients from both groups were diagnosed with a UTI at visit (indwelling catheters vs IC: 8% (16/206) vs 8% (24/299); p = 0·782), and the number of UTIs within the past 12 months was not significantly different between groups. Overall, Escherichia coli (21%), Enterococcus faecalis (17%), and Klebsiella spp. (12%) were the most frequently detected bacteria. Conclusions: In this cohort of patients with NLUTD, we did not find relevant differences in UTI frequency between groups. These results suggest that UTI-related concerns should not be given undue emphasis when counseling patients for catheter-related bladder emptying methods.
- 2 August 2023
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 23 (1) , 1-10
Open AccessIndwelling catheter vs intermittent catheterization: is there a difference in UTI susceptibility?
Background: Patients with neurogenic lower urinary tract dysfunction (NLUTD) often rely on some type of catheterization for bladder emptying. Intermittent catheterization (IC) is considered the gold standard and is preferred over continuous catheterization, since it is considered to cause fewer urinary tract infections (UTIs) than indwelling catheterization. The main objective of our study was to describe UTI prevalence (at visit) and incidence (within the last 12 months) and urine culture characteristics between patients using an indwelling catheter versus (vs) those performing IC. Methods: In this cross-sectional study, we prospectively evaluated from 02/2020 to 01/2021 patients with NLUTD undergoing urine cultures for prophylactic reasons or due to UTI symptoms. At visit, all patients underwent a standardized interview on current UTI symptoms as well as UTI history and antibiotic consumption within the past year. Patients using an indwelling catheter (n = 206) or IC (n = 299) were included in the analysis. The main outcome was between-group differences regarding UTI characteristics. Results: Patients using an indwelling catheter were older (indwelling catheter vs IC: median 66 (Q1-Q3: 55—77) vs 55 (42—67) years of age) and showed a higher Charlson comorbidity index (indwelling catheter vs IC: median 4 (Q1-Q3: 2–6) vs 2 (1–4) (both p < 0·001). A total of 40 patients from both groups were diagnosed with a UTI at visit (indwelling catheters vs IC: 8% (16/206) vs 8% (24/299); p = 0·782), and the number of UTIs within the past 12 months was not significantly different between groups. Overall, Escherichia coli (21%), Enterococcus faecalis (17%), and Klebsiella spp. (12%) were the most frequently detected bacteria. Conclusions: In this cohort of patients with NLUTD, we did not find relevant differences in UTI frequency between groups. These results suggest that UTI-related concerns should not be given undue emphasis when counseling patients for catheter-related bladder emptying methods.
- Open Access
- 13 June 2023
- Published by Wiley in BJU International
- Vol. 132 (3) , 343-352
bTUNED : transcutaneous tibial nerve stimulation for neurogenic lower urinary tract dysfunction
Objective: To present the protocol for a randomized controlled trial (RCT) evaluating the efficacy and safety of transcutaneous tibial nerve stimulation (TTNS) for refractory neurogenic lower urinary tract dysfunction (NLUTD). Study Design and Results: bTUNED (bladder and TranscUtaneous tibial Nerve stimulation for nEurogenic lower urinary tract Dysfunction) is an international multicentre, sham‐controlled, double‐blind RCT investigating the efficacy and safety of TTNS. The primary outcome is success of TTNS, defined as improvements in key bladder diary variables at study end compared to baseline values. The focus of the treatment is defined by the Self‐Assessment Goal Achievement (SAGA) questionnaire. Secondary outcomes are the effect of TTNS on urodynamic, neurophysiological, and bowel function outcome measures, as well as the safety of TTNS. Conclusions: A total of 240 patients with refractory NLUTD will be included and randomized 1:1 into the verum or sham TTNS group from March 2020 until August 2026. TTNS will be performed twice a week for 30 min during 6 weeks. The patients will attend baseline assessments, 12 treatment visits and follow‐up assessments at the study end.
- 13 June 2023
- Published by Wiley in BJU International
- Vol. 132 (3) , 343-352
Open AccessbTUNED : transcutaneous tibial nerve stimulation for neurogenic lower urinary tract dysfunction
Objective: To present the protocol for a randomized controlled trial (RCT) evaluating the efficacy and safety of transcutaneous tibial nerve stimulation (TTNS) for refractory neurogenic lower urinary tract dysfunction (NLUTD). Study Design and Results: bTUNED (bladder and TranscUtaneous tibial Nerve stimulation for nEurogenic lower urinary tract Dysfunction) is an international multicentre, sham‐controlled, double‐blind RCT investigating the efficacy and safety of TTNS. The primary outcome is success of TTNS, defined as improvements in key bladder diary variables at study end compared to baseline values. The focus of the treatment is defined by the Self‐Assessment Goal Achievement (SAGA) questionnaire. Secondary outcomes are the effect of TTNS on urodynamic, neurophysiological, and bowel function outcome measures, as well as the safety of TTNS. Conclusions: A total of 240 patients with refractory NLUTD will be included and randomized 1:1 into the verum or sham TTNS group from March 2020 until August 2026. TTNS will be performed twice a week for 30 min during 6 weeks. The patients will attend baseline assessments, 12 treatment visits and follow‐up assessments at the study end.
- Open Access
- 1 January 2023
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 209 (1) , 225-232
Neurogenic Lower Urinary Tract Dysfunction in the First Year After Spinal Cord Injury: A Descriptive Study of Urodynamic Findings
Purpose:We aimed to provide a real-world description of neurogenic lower urinary tract dysfunction within the first year after spinal cord injury with a focus on unfavorable urodynamic para...
- 1 January 2023
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 209 (1) , 225-232
Open AccessNeurogenic Lower Urinary Tract Dysfunction in the First Year After Spinal Cord Injury: A Descriptive Study of Urodynamic Findings
Purpose:We aimed to provide a real-world description of neurogenic lower urinary tract dysfunction within the first year after spinal cord injury with a focus on unfavorable urodynamic para...
- Open Access
- 28 October 2022
- Published by Wiley in BJU International
- Vol. 131 (4) , 503-512
Temporal development of unfavourable urodynamic parameters during the first year after spinal cord injury
Objectives: To describe the temporal development of and risk factors for the occurrence of unfavourable urodynamic parameters during the first year after spinal cord injury (SCI). Patients and Methods: This population‐based longitudinal study used data from 97 adult patients with a single‐event traumatic or ischaemic SCI who underwent video‐urodynamic investigation (UDI) at a university SCI centre. The first occurrences of unfavourable urodynamic parameters (detrusor overactivity combined with detrusor sphincter dyssynergia [DO‐DSD], maximum storage detrusor pressure ≥40 cmH 2 O, bladder compliance 2 O, vesico‐ureteric reflux [VUR] and any unfavourable parameter [composite outcome]) were evaluated using time‐to‐event analysis. Results: The majority of the population (87/97 [90%]) had at least one unfavourable urodynamic parameter. Most unfavourable urodynamic parameters were initially identified during the 1‐ or 3‐month UDI, including 92% of the DO‐DSD (78/85), 82% of the maximum storage pressure ≥40 cmH 2 O (31/38), and 100% of the VUR (seven of seven) observations. No low bladder compliance was observed. The risk of DO‐DSD was elevated in patients with thoracic SCI compared to those with lumbar SCI (adjusted hazard ratio [aHR] 2.38, 95% confidence interval [CI] 1.16–4.89). Risk of maximum storage detrusor pressure ≥40 cmH 2 O was higher in males than females (aHR 8.33, 95% CI 2.51–27.66), in patients with a cervical SCI compared to those with lumbar SCI (aHR 14.89, 95% CI 3.28–67.55), and in patients with AIS Grade B or C compared to AIS Grade D SCI (aHR 6.17, 95% CI 1.78–21.39). No risk factors were identified for the composite outcome of any unfavourable urodynamic parameter. Conclusions: The first UDI should take place within 3 months after SCI as to facilitate early diagnosis of unfavourable urodynamic parameters and timely treatment. Neuro‐urological guidelines and individualised management strategies for patients with SCI may be strengthened by considering sex and SCI characteristics in the scheduling of UDIs.
- 28 October 2022
- Published by Wiley in BJU International
- Vol. 131 (4) , 503-512
Open AccessTemporal development of unfavourable urodynamic parameters during the first year after spinal cord injury
Objectives: To describe the temporal development of and risk factors for the occurrence of unfavourable urodynamic parameters during the first year after spinal cord injury (SCI). Patients and Methods: This population‐based longitudinal study used data from 97 adult patients with a single‐event traumatic or ischaemic SCI who underwent video‐urodynamic investigation (UDI) at a university SCI centre. The first occurrences of unfavourable urodynamic parameters (detrusor overactivity combined with detrusor sphincter dyssynergia [DO‐DSD], maximum storage detrusor pressure ≥40 cmH 2 O, bladder compliance 2 O, vesico‐ureteric reflux [VUR] and any unfavourable parameter [composite outcome]) were evaluated using time‐to‐event analysis. Results: The majority of the population (87/97 [90%]) had at least one unfavourable urodynamic parameter. Most unfavourable urodynamic parameters were initially identified during the 1‐ or 3‐month UDI, including 92% of the DO‐DSD (78/85), 82% of the maximum storage pressure ≥40 cmH 2 O (31/38), and 100% of the VUR (seven of seven) observations. No low bladder compliance was observed. The risk of DO‐DSD was elevated in patients with thoracic SCI compared to those with lumbar SCI (adjusted hazard ratio [aHR] 2.38, 95% confidence interval [CI] 1.16–4.89). Risk of maximum storage detrusor pressure ≥40 cmH 2 O was higher in males than females (aHR 8.33, 95% CI 2.51–27.66), in patients with a cervical SCI compared to those with lumbar SCI (aHR 14.89, 95% CI 3.28–67.55), and in patients with AIS Grade B or C compared to AIS Grade D SCI (aHR 6.17, 95% CI 1.78–21.39). No risk factors were identified for the composite outcome of any unfavourable urodynamic parameter. Conclusions: The first UDI should take place within 3 months after SCI as to facilitate early diagnosis of unfavourable urodynamic parameters and timely treatment. Neuro‐urological guidelines and individualised management strategies for patients with SCI may be strengthened by considering sex and SCI characteristics in the scheduling of UDIs.